ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1519

Pleuropulmonary Manifestations in Rheumatoid Arthritis Patients

Suzan Attar1 and Omar Amoudi2, 1Internal Medicine, MBBCH. FRCPC. ABIM, Jeddah, Saudi Arabia, 2Internal Medicine, FRCPC, Jeddah, Saudi Arabia

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: pulmonary complications and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Pulmonary involvement in rheumatoid
arthritis (RA) patients is associated with high morbidity and mortality. Nevertheless,
limited data are available regarding such lung complications in the Middle East,
especially in the Kingdome of Saudi Arabia. The objective of the current  study
were to  determine the prevalence of pleuropulmonary manifestations and to
identify the risk factors  predicting  lung involvement.

Methods: This was a retrospective
study involving 419 RA patients diagnosed at a tertiary center over a 12.5-year
period. RA was diagnosed on the  2010 American College of Rheumatology (ACR)
criteria. The frequency of pulmonary manifestations were recorded based on
combined results from the chest X-rays, pulmonary function tests, and high
resolution computed tomography (HRCT) scan on the chest.

Results: The overall
frequency of lung involvement in RA was 25.8%. Pneumonia
and bronchiectasis
were
the
most common abnormalities (36% and 35% respectively). HRCT scan was more sensitive in detecting of pleuropulmonary
abnormalities. . The presence of comorbid illness (OR=3.19, 95% CI: 2.02–5.1),
male gender (OR=2.4, 95% CI: 1.3–4.24), and the presence of extra-articular manifestations (OR=2.35, 95% CI:
0.4–4.01) were significantly predicting lung involvement .

Conclusion: Pneumonia and bronchiactasis were the most common
abnormalities seen in RA patients in Saudi Arabia. This finding were comparable
with other studies.. The presence of comorbidity , male gender and
extra-articular manifestation were statistically associated with lung
involvement .


Disclosure: S. Attar, None; O. Amoudi, None.

To cite this abstract in AMA style:

Attar S, Amoudi O. Pleuropulmonary Manifestations in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/pleuropulmonary-manifestations-in-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pleuropulmonary-manifestations-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology